Ingunn Munch Lindvig
Consejero General en BIOINVENT INTERNATIONAL AB .
Perfil
Ingunn Munch Lindvig is currently the Senior Vice President-Regulatory Affairs at BioInvent International AB since 2023.
Previously, she worked as the Head-Regulatory Affairs at Nordic Nanovector ASA and as the Vice President & Head-Regulatory Affairs at Circio Holding ASA. Dr. Lindvig holds a doctorate degree from the University of Oslo.
Cargos activos de Ingunn Munch Lindvig
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOINVENT INTERNATIONAL AB | Consejero General | 12/06/2023 |
Antiguos cargos conocidos de Ingunn Munch Lindvig.
| Empresas | Cargo | Fin |
|---|---|---|
| THOR MEDICAL | Consejero General | - |
| CIRCIO HOLDING ASA | Consejero General | - |
Formación de Ingunn Munch Lindvig.
| University of Oslo | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| CIRCIO HOLDING ASA | Health Technology |
| BIOINVENT INTERNATIONAL AB | Health Technology |
| Empresas privadas | 1 |
|---|---|
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
- Bolsa de valores
- Insiders
- Ingunn Munch Lindvig